Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial Comparing Standard of Care Adjuvant Temozolomide With or Without 5-Aminolevulinic Acid (5-ALA) With Concomitant Low Intensity Diffuse Ultrasound (LIDUa) Sonodynamic Therapy (SDT) System In Patients With Newly Diagnosed Glioblastoma After Completion of Chemoradiotherapy
Objective
Compare progression-free survival of patients by treatment arm
Compare overall survival of patients by treatment arm
Compare treatment arms at specific time points Evaluate safety Evaluate time to next treatment
